| Peter C Link, MD | |
|
209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 | |
| (253) 596-3300 | |
| Not Available |
| Full Name | Peter C Link |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 209 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497810444 | NPI | - | NPPES |
| P00745323 | Other | WA | RAIL RAOD |
| 8138760 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD00028228 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter C Link, MD Po Box 34584, Seattle, WA 98124-1584 Ph: (509) 241-7349 | Peter C Link, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 |
News Archive
While soy may be beneficial to women in a variety of ways, research in monkeys suggests that it could have an adverse effect on the behavior of men, according to researchers from Wake Forest University Baptist Medical Center.
Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumors, according to research presented at the 2019 NCRI Cancer Conference.
Five additional pharmaceutical companies have joined a National Institutes of Health-led effort to help scientists research promising new treatments for patients. Funding and molecular compound information is available now for the initial phase of the recently unveiled Discovering New Therapeutic Uses for Existing Molecules program.
Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore™ Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals.
Catalyst Health Solutions, Inc. today announced that it plans to sell 5,500,000 shares of its common stock, subject to market and other conditions, of which 4,500,000 shares will be sold by the Company and 1,000,000 shares will be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., in an underwritten public offering pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission.
› Verified 9 days ago
Jesse Lee Mierzwiak, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3124 S 19th St, Ste 320, Tacoma, WA 98405 Phone: 253-301-5100 | |
Dr. Scott Paul Cuda, M.D. Urology Medicare: Medicare Enrolled Practice Location: Madigan Army Medical Center 9040 Jackson Avenu, Tacoma, WA 98431 Phone: 253-968-2300 | |
Michael Charles Deberardinis, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-372-7102 | |
Zachary Evan Panfili, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Dr. William Matthew Dean, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 314 Martin Luther King Jr Way, Suite 103, Tacoma, WA 98405 Phone: 253-272-4013 Fax: 253-627-5367 | |
Carolyn Anne Salter, M.D. Urology Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-2252 | |
Timothy Brand, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-2300 |